Covid, FDA and vaccines
Digest more
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use of vaccines. Yet his regulators are promising big changes that cloud the outlook for what shots might even be available.
Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S. regulatory approval for its COVID-19 vaccine, albeit with new conditions, which helped allay some investor concerns over the future of the shot.
FDA set to change requirements to get vaccines approved as RFK Jr continues to push skepticism about their use - New FDA framework on changes coronavirus vaccine approval will be released “in the coming days,
But the FDA and the Centers for Disease Control and Prevention (CDC) released a safety notice on May 9 recommending that adults over 60 years old pause use of the vaccine due to fatal complications. “FDA and CDC will continue the evaluation of post-marketing safety reports for Ixchiq,” the release reads.